Syndax Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Syndax Pharmaceuticals Inc
TickerSNDX
CIK #0001395937
CUSIP87164F105
SectorLife Sciences - Pharmaceutical Preparations
Address460 Totten Pond Road Suite 650, Waltham, MA 02451
Source [EDGAR]
CIK Filing 2011 - 2025
[0001395937] 10-K
[0001395937] 10-Q
[0001395937] 3
[0001395937] 4
[0001395937] 8-K
[0001395937] D
[0001395937] SC 13D
[0001395937] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-08-18] 0.0
Goldman Sachs Group Inc Syndax Pharmaceuticals Inc [2025-02-12] 0.0
Morgan Stanley Syndax Pharmaceuticals Inc [2025-02-05] 0.0
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-01-22] 0.0
Kynam Capital Management LP Syndax Pharmaceuticals Inc [2024-02-14] 6.67
Vanguard Group Inc Syndax Pharmaceuticals Inc [2024-02-13] 5.11
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2023-10-31] 4.5
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2023-01-10] 11.72
Nantahala Capital Management LLC Syndax Pharmaceuticals Inc [2022-02-14] 5.8
Frazier Life Sciences Public Fund LP Syndax Pharmaceuticals Inc [2021-12-23] 3.2
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2021-05-10] 5.6
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2021-05-03] 5.56
BlackRock Inc Syndax Pharmaceuticals Inc [2021-02-02] 5.0
Avidity Partners Management LP Syndax Pharmaceuticals Inc [2020-11-04] 6.7
Boxer Capital LLC Syndax Pharmaceuticals Inc [2020-05-11] 0.0
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2019-10-09] 6.1
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2019-04-08] 5.72
BlackRock Inc Syndax Pharmaceuticals Inc [2019-02-08] 6.3
683 Capital Management LLC Syndax Pharmaceuticals Inc [2018-11-29] 5.0
Biotechnology Value Fund L P Syndax Pharmaceuticals Inc [2017-11-14] 3.9
MPM BioVentures IV QP LP Syndax Pharmaceuticals Inc [2017-02-09] 0.9
BlackRock Inc Syndax Pharmaceuticals Inc [2017-01-30] 8.0
Domain Partners VIII LP Syndax Pharmaceuticals Inc [2017-01-09] 4.2
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2016-09-12] 11.0
FMR LLC Syndax Pharmaceuticals Inc [2016-04-11] 0.0
Form 3/4/5 Filer 2011 - 2025
Podlesak Dennis
Syndax Pharmaceuticals Inc
Goldan Keith A.
Metzger Michael A
Huber Martin H. Jr.
Botwood Nicholas A.J.
Katkin Keith
Gallagher Neil
Meury William
Rizo Aleksandra
Jarrett Jennifer
Legault Pierre
Morrison Briggs
Ordentlich Peter
Nolte Alexander
Madigan Catherine
Sabus Steve M
Meyers Michael L.
Egros Fabrice
Karydas Daphne
Shea Richard P
BVF Partners OS Ltd.
Lampert Mark N
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
Evnin Luke
Chen Henry
Sledge George W. Jr.
Royston IVOR
Kamdar Kim P.
Scopa James Paul
Foley Todd
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV LLC
Kailian Vaughn M
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV Strategic Fund, L.P.
Gadicke Ansbert
MPM BioVentures IV GP LLC
MPM BioVentures IV QP LP
Blair James C
Treu Jesse I
Vitullo Nicole
DP VIII Associates, L.P.
Dovey Brian H
Halak Brian K
DP VI Associates, L.P.
Domain Partners VI, L.P.
Domain Partners VIII, L.P.
Shah Nimesh
Domain Associates
Shaw Allan
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 9,828,330 10,453,624
Kynam Capital Management LP [2025-06-30] SOLE 8,520,000 8,520,000
Goldman Sachs Group Inc [2025-06-30] DFND 5,707,703 5,738,287
Vanguard Group Inc [2025-06-30] SOLE 0 4,846,493
Eversept Partners LP [2025-06-30] SOLE 4,065,355 4,065,355
Bank of America Corp /DE/ [2025-06-30] DFND 12,573 3,838,872
State Street Corp [2025-06-30] DFND 3,237,385 3,442,752
Stempoint Capital LP [2025-06-30] SOLE 2,092,432 2,372,634
Franklin Resources Inc [2025-06-30] DFND 2,359,543 2,359,677
Point72 Asset Management LP [2025-06-30] DFND 0 2,127,467
Catalio Capital Management LP [2025-06-30] SOLE 2,104,512 2,104,512
Kingdon Capital Management LLC [2025-06-30] DFND 2,100,000 2,100,000
Geode Capital Management LLC [2025-06-30] DFND 2,049,350 2,049,350
Assenagon Asset Management S.A. [2025-06-30] SOLE 2,039,987 2,039,987
Woodline Partners LP [2025-06-30] SOLE 1,892,751 1,892,751
Caption Management LLC [2025-06-30] SOLE 1,764,771 1,764,771
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,665,916 1,665,916
Millennium Management LLC [2025-06-30] SOLE 1,598,613 1,598,613
Sphera Funds Management Ltd [2025-06-30] DFND 1,571,564 1,571,564
Sofinnova Investments Inc [2025-06-30] SOLE 1,524,440 1,524,440
BNP Paribas Asset Management Holding S.A. [2025-06-30] DFND 0 1,445,440
UBS Group AG [2025-06-30] DFND 1,429,853 1,435,415
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,432,440 1,432,440
Eventide Asset Management LLC [2025-06-30] SOLE 1,414,081 1,414,081
Aisling Capital Management LP [2025-06-30] SOLE 1,316,806 1,316,806
Soleus Capital Management LP [2025-06-30] SOLE 1,092,110 1,092,110
ProSight Management LP [2025-06-30] SOLE 1,079,673 1,079,673
Granahan Investment Management LLC [2025-06-30] SOLE 857,207 991,388
Parkman Healthcare Partners LLC [2025-06-30] SOLE 867,813 867,813
Morgan Stanley [2025-06-30] DFND 812,990 849,236
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com